Changes

Jump to navigation Jump to search

Tumours of Haematopoietic and Lymphoid Tissues (view source)

Revision as of 09:11, 3 March 2021

59 bytes added ,  09:11, 3 March 2021
no edit summary
Line 1: Line 1: −
== Myeloproliferative Neoplasms (MPN) ==
+
==Myeloproliferative Neoplasms (MPN)==
 +
 
 
*[[Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive]]
 
*[[Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive]]
 
*[[Chronic Neutrophilic Leukemia (CNL)]]
 
*[[Chronic Neutrophilic Leukemia (CNL)]]
Line 8: Line 9:  
*[[Myeloproliferative Neoplasm (MPN), Unclassifiable]]
 
*[[Myeloproliferative Neoplasm (MPN), Unclassifiable]]
   −
== Mastocytosis ==
+
==Mastocytosis==
 +
 
 
*[[Cutaneous Mastocytosis]]
 
*[[Cutaneous Mastocytosis]]
 
*[[Systemic Mastocytosis]]
 
*[[Systemic Mastocytosis]]
 
*[[Mast Cell Sarcoma]]
 
*[[Mast Cell Sarcoma]]
   −
== Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2 ==
+
==Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2==
 +
 
 
*[[Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement]]
 
*[[Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement]]
 
*[[Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement]]
 
*[[Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement]]
Line 19: Line 22:  
*[[Myeloid/Lymphoid Neoplasms with PCM1-JAK2]]
 
*[[Myeloid/Lymphoid Neoplasms with PCM1-JAK2]]
   −
== Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) ==
+
==Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)==
 +
 
 
*[[Chronic Myelomonocytic Leukemia (CMML)]]
 
*[[Chronic Myelomonocytic Leukemia (CMML)]]
 
*[[Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative]]
 
*[[Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative]]
Line 26: Line 30:  
*[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]]
 
*[[Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable|MDS/MPN, Unclassifiable]]
   −
== Myelodysplastic Syndromes (MDS) ==
+
==Myelodysplastic Syndromes (MDS)==
 +
 
 
*[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]]
 
*[[Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia|MDS with Single Lineage Dysplasia]]
 
*[[Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)|MDS with Ring Sideroblasts (MDS-RS)]]
 
*[[Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)|MDS with Ring Sideroblasts (MDS-RS)]]
Line 36: Line 41:  
*[[Refractory Cytopenia of Childhood]]
 
*[[Refractory Cytopenia of Childhood]]
   −
== Myeloid Neoplasms with Germline Predisposition ==
+
==Myeloid Neoplasms with Germline Predisposition==
    
*[[Acute Myeloid Leukaemia with Germline CEBPA Mutation]]
 
*[[Acute Myeloid Leukaemia with Germline CEBPA Mutation]]
Line 45: Line 50:  
*[[Myeloid Neoplasms with Germline GATA2 Mutation]]
 
*[[Myeloid Neoplasms with Germline GATA2 Mutation]]
   −
== Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms ==
+
==Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms==
 +
 
 
*[[Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities|AML with Recurrent Genetic Abnormalities]]
 
*[[Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities|AML with Recurrent Genetic Abnormalities]]
   Line 83: Line 89:  
   - [[Myeloid Leukemia Associated with Down Syndrome]]
 
   - [[Myeloid Leukemia Associated with Down Syndrome]]
   −
== Blastic Plasmacytoid Dendritic Cell Neoplasm ==
+
==Blastic Plasmacytoid Dendritic Cell Neoplasm==
 +
 
 
*[[Blastic Plasmacytoid Dendritic Cell Neoplasm]]
 
*[[Blastic Plasmacytoid Dendritic Cell Neoplasm]]
   −
== Acute Leukemias of Ambiguous Lineage (MPAL) ==
+
==Acute Leukemias of Ambiguous Lineage (MPAL)==
 +
 
 
*[[Acute Leukemias of Ambiguous Lineage]]
 
*[[Acute Leukemias of Ambiguous Lineage]]
   Line 97: Line 105:  
   - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]]
 
   - [[Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)]]
   −
== Precursor Lymphoid Neoplasms (B-ALL, T-ALL) ==
+
==Precursor Lymphoid Neoplasms (B-ALL, T-ALL)==
 +
 
 
*[[B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]]
 
*[[B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities|B-Lymphoblastic Leukemia/Lymphoma (B-ALL) with Recurrent Genetic Abnormalities]]
   Line 116: Line 125:  
   - [[NK-Lymphoblastic Leukemia/Lymphoma]]
 
   - [[NK-Lymphoblastic Leukemia/Lymphoma]]
   −
== Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas) ==
+
==Mature B-Cell Neoplasms (CLL, Plasma Cell Neoplasms, Non-Hodgkin B-cell Lymphomas)==
 +
 
 
*[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]]
 
*[[Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma]]
 +
 
   - [[Monoclonal B-cell Lymphocytosis]]
 
   - [[Monoclonal B-cell Lymphocytosis]]
   Line 127: Line 138:     
*[[Splenic B-cell Lymphoma/Leukemia, Unclassifiable]]
 
*[[Splenic B-cell Lymphoma/Leukemia, Unclassifiable]]
 +
 
   - [[Splenic Diffuse Red Pulp Small B-cell Lymphoma]]
 
   - [[Splenic Diffuse Red Pulp Small B-cell Lymphoma]]
 
   - [[Hairy Cell Leukemia Variant]]
 
   - [[Hairy Cell Leukemia Variant]]
    
*[[Lymphoplasmacytic Lymphoma]]
 
*[[Lymphoplasmacytic Lymphoma]]
 +
 
   - [[Waldenstrom Macroglobulinemia]]
 
   - [[Waldenstrom Macroglobulinemia]]
   Line 136: Line 149:     
*[[Heavy Chain Diseases]]
 
*[[Heavy Chain Diseases]]
 +
 
   - [[Mu Heavy Chain Disease]]
 
   - [[Mu Heavy Chain Disease]]
 
   - [[Gamma Heavy Chain Disease]]
 
   - [[Gamma Heavy Chain Disease]]
Line 141: Line 155:     
*[[Plasma Cell Neoplasms]]
 
*[[Plasma Cell Neoplasms]]
 +
 
   - [[Non-IgM Monoclonal Gammopathy of Undetermined Significance]]
 
   - [[Non-IgM Monoclonal Gammopathy of Undetermined Significance]]
 
   - [[Plasma Cell Myeloma]]
 
   - [[Plasma Cell Myeloma]]
Line 155: Line 170:     
*[[Nodal Marginal Zone Lymphoma]]
 
*[[Nodal Marginal Zone Lymphoma]]
 +
 
   - [[Paediatric Nodal Marginal Zone Lymphoma]]
 
   - [[Paediatric Nodal Marginal Zone Lymphoma]]
    
*[[Follicular Lymphoma]]
 
*[[Follicular Lymphoma]]
 +
 
   - [[Testicular Follicular Lymphoma]]
 
   - [[Testicular Follicular Lymphoma]]
 
   - [[In Situ Follicular Neoplasia]]
 
   - [[In Situ Follicular Neoplasia]]
Line 169: Line 186:     
*[[Mantle Cell Lymphoma]]
 
*[[Mantle Cell Lymphoma]]
 +
 
   - [[Leukemic Non-Nodal Mantle Cell Lymphoma]]
 
   - [[Leukemic Non-Nodal Mantle Cell Lymphoma]]
 
   - [[In Situ Mantle Cell Neoplasia]]
 
   - [[In Situ Mantle Cell Neoplasia]]
Line 185: Line 203:     
*[[Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation]]
 
*[[Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation]]
 +
 
   - [[Fibrin-Associated Diffuse Large B-cell Lymphoma]]
 
   - [[Fibrin-Associated Diffuse Large B-cell Lymphoma]]
   Line 200: Line 219:     
*[[HHV8-Associated Lymphoproliferative Disorders]]
 
*[[HHV8-Associated Lymphoproliferative Disorders]]
 +
 
   - [[Multicentric Castleman Disease]]
 
   - [[Multicentric Castleman Disease]]
 
   - [[HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)]]
 
   - [[HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)]]
Line 209: Line 229:     
*[[High-Grade B-cell Lymphoma]]
 
*[[High-Grade B-cell Lymphoma]]
 +
 
   - [[High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements]]
 
   - [[High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements]]
 
   - [[High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)]]
 
   - [[High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)]]
Line 214: Line 235:  
*[[B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]]
 
*[[B-cell Lymphoma, Unclassifiable, with Features Intermediate Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma]]
   −
== Mature T- and NK-cell Neoplasms ==
+
==Mature T- and NK-cell Neoplasms==
 +
 
 
*[[T-cell Prolymphocytic Leukemia]]
 
*[[T-cell Prolymphocytic Leukemia]]
   Line 224: Line 246:     
*[[EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood]]
 
*[[EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood]]
 +
 
   - [[Systemic EBV-Positive T-cell Lymphoma of Childhood]]
 
   - [[Systemic EBV-Positive T-cell Lymphoma of Childhood]]
 
   - [[Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form]]
 
   - [[Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form]]
Line 234: Line 257:     
*[[Intestinal T-cell Lymphoma]]
 
*[[Intestinal T-cell Lymphoma]]
 +
 
   - [[Enteropathy-Associated T-cell Lymphoma]]
 
   - [[Enteropathy-Associated T-cell Lymphoma]]
 
   - [[Monomorphic Epitheliotropic Intestinal T-cell Lymphoma]]
 
   - [[Monomorphic Epitheliotropic Intestinal T-cell Lymphoma]]
Line 248: Line 272:     
*[[Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders]]
 
*[[Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders]]
 +
 
   - [[Lymphomatoid Papulosis]]
 
   - [[Lymphomatoid Papulosis]]
 
   - [[Primary Cutaneous Anaplastic Large Cell Lymphoma]]
 
   - [[Primary Cutaneous Anaplastic Large Cell Lymphoma]]
    
*[[Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes]]
 
*[[Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes]]
 +
 
   - [[Primary Cutaneous Gamma Delta T-cell Lymphoma]]
 
   - [[Primary Cutaneous Gamma Delta T-cell Lymphoma]]
 
   - [[Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma]]
 
   - [[Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma]]
Line 260: Line 286:     
*[[Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]]
 
*[[Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin]]
 +
 
   - [[Angioimmunoblastic T-cell Lymphoma]]
 
   - [[Angioimmunoblastic T-cell Lymphoma]]
 
   - [[Follicular T-cell Lymphoma]]
 
   - [[Follicular T-cell Lymphoma]]
Line 270: Line 297:  
*[[Breast Implant-Associated Anaplastic Large Cell Lymphoma]]
 
*[[Breast Implant-Associated Anaplastic Large Cell Lymphoma]]
   −
== Hodgkin Lymphomas==  
+
==Hodgkin Lymphomas==  
 +
 
 
*[[Nodular Lymphocyte Predominant Hodgkin Lymphoma]]
 
*[[Nodular Lymphocyte Predominant Hodgkin Lymphoma]]
    
*[[Classic Hodgkin Lymphoma]]
 
*[[Classic Hodgkin Lymphoma]]
 +
 
   - [[Nodular Sclerosis Classic Hodgkin Lymphoma]]
 
   - [[Nodular Sclerosis Classic Hodgkin Lymphoma]]
 
   - [[Lymphocyte-Rich Classic Hodgkin Lymphoma]]
 
   - [[Lymphocyte-Rich Classic Hodgkin Lymphoma]]
Line 279: Line 308:  
   - [[Lymphocyte-Depleted Classic Hodgkin Lymphoma]]
 
   - [[Lymphocyte-Depleted Classic Hodgkin Lymphoma]]
   −
== Immunodeficiency-Associated Lymphoproliferative Disorders==  
+
==Immunodeficiency-Associated Lymphoproliferative Disorders==  
 +
 
 
*[[Lymphomas Associated with HIV Infection]]
 
*[[Lymphomas Associated with HIV Infection]]
    
*[[Post-Transplant Lymphoproliferative Disorders]]
 
*[[Post-Transplant Lymphoproliferative Disorders]]
 +
 
   - [[Non-Destructive Post-Transplant Lymphoproliferative Disorders]]
 
   - [[Non-Destructive Post-Transplant Lymphoproliferative Disorders]]
 
   - [[Polymorphic Post-Transplant Lymphoproliferative Disorders]]
 
   - [[Polymorphic Post-Transplant Lymphoproliferative Disorders]]
Line 292: Line 323:  
*[[Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders]]
 
*[[Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders]]
   −
== Histiocytic and Dendritic Cell Neoplasms ==  
+
==Histiocytic and Dendritic Cell Neoplasms==  
 +
 
 
*[[Histiocytic Sarcoma]]
 
*[[Histiocytic Sarcoma]]
    
*[[Tumors Derived From Langerhans Cells]]
 
*[[Tumors Derived From Langerhans Cells]]
 +
 
   - [[Langerhans Cell Histiocytosis]]
 
   - [[Langerhans Cell Histiocytosis]]
 
   - [[Langerhans Cell Sarcoma]]
 
   - [[Langerhans Cell Sarcoma]]
Line 304: Line 337:     
*[[Follicular Dendritic Cell Sarcoma]]
 
*[[Follicular Dendritic Cell Sarcoma]]
 +
 
   - [[Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma]]
 
   - [[Inflammatory Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma]]
   Line 313: Line 347:     
NOTES
 
NOTES
−
The hierarchical tumour classification structure displayed on this page is reproduced from the WHO Classification of Tumours with permission from the copyright holder, ©International Agency for Research on Cancer.
+
The hierarchical tumour classification structure displayed on this page is reproduced from the [https://tumourclassification.iarc.who.int/welcome/ WHO Classification of Tumours] with permission from the copyright holder, ©International Agency for Research on Cancer.
Retrieved from "https://ccga.io/index.php/Special:MobileDiff/9848"

Navigation menu